Janus Henderson Group’s 89bio ETNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-5,378,185
| Closed | -$79.1M | – | 2426 |
|
|
2025
Q3 | $79.1M | Sell |
5,378,185
-15,410,178
| -74% | -$157M | 0.04% | 317 |
|
|
2025
Q2 | $204M | Buy |
20,788,363
+325,458
| +2% | +$2.69M | 0.1% | 186 |
|
|
2025
Q1 | $165M | Buy |
20,462,905
+3,948,849
| +24% | +$34.5M | 0.09% | 201 |
|
|
2024
Q4 | $129M | Buy |
16,514,056
+1,355,838
| +9% | +$11.2M | 0.07% | 249 |
|
|
2024
Q3 | $112M | Buy |
15,158,218
+1,882,108
| +14% | +$15.8M | 0.06% | 262 |
|
|
2024
Q2 | $106M | Buy |
13,276,110
+672,728
| +5% | +$6.01M | 0.06% | 254 |
|
|
2024
Q1 | $147M | Buy |
12,603,382
+3,688,241
| +41% | +$40.8M | 0.08% | 220 |
|
|
2023
Q4 | $99.6M | Buy |
8,915,141
+4,885,938
| +121% | +$44.9M | 0.06% | 252 |
|
|
2023
Q3 | $62.2M | Sell |
4,029,203
-90,715
| -2% | -$1.52M | 0.04% | 322 |
|
|
2023
Q2 | $78M | Buy |
4,119,918
+373,880
| +10% | +$6.57M | 0.05% | 296 |
|
|
2023
Q1 | $57.1M | Buy |
3,746,038
+2,726,659
| +267% | +$35.6M | 0.04% | 355 |
|
|
2022
Q4 | $13M | Buy |
1,019,379
+231,387
| +29% | +$2.08M | 0.01% | 660 |
|
|
2022
Q3 | $4.56M | Sell |
787,992
-902,148
| -53% | -$3.96M | ﹤0.01% | 843 |
|
|
2022
Q2 | $5.45M | Buy |
+1,690,140
| New | +$5.1M | ﹤0.01% | 823 |
|
|
2020
Q4 | – | Sell |
-60,650
| Closed | -$1.56M | – | 1397 |
|
|
2020
Q3 | $1.56M | Buy |
+60,650
| New | +$1.92M | ﹤0.01% | 1097 |
|
Other funds holding ETNB
Janus Henderson Group's ETNB Position: Q4 2025 in Review
Janus Henderson Group sold out of 89bio (ETNB) in Q4 2025, closing a stake of 5,378,185 shares — an estimated $79.1M sold.
Janus Henderson Group first reported a position in ETNB in Q3 2020 and held it in 15 quarters. The position peaked at $204M in Q2 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.
- Janus Henderson Group reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
- Janus Henderson Group sold 5,378,185 89bio shares in Q4 2025, an estimated $79.1M.
- Janus Henderson Group first reported a position in 89bio in Q3 2020 and held it in 15 quarters.
- Janus Henderson Group's 89bio position peaked at $204M in Q2 2025.
- 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.
Based on Janus Henderson Group's 13F filing for Q4 2025, filed 17 Feb 2026.